Compare ARK Genomic Revolution ETF (ARKG) vs NetFlix Inc (NFLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs NetFlix Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while NetFlix Inc trades at $73.95 (market cap $308.95B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, NetFlix Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | NFLX | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $127.42 |
52-Week Low | $23.09 | $70.91 |
Market Cap | — | $308.95B |
Enterprise Value | — | $311.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Netflix (NFLX) trades at $73.37, down 2.78% on the day, reflecting recent bearish momentum despite strong fundamentals. The stock shows robust revenue growth, with 2025 revenue reaching $45.18 billion and net income at $10.98 billion, while technical indicators signal near-term weakness. Analyst sentiment remains positive with a consensus price target of $111.80, though recent news highlights concerns over its losing streak and competitive pressures in the streaming sector.
The outlook for NFLX is mixed; strong profitability and expanding ad revenue offer upside, but technical bearishness and market volatility pose risks. Investors should weigh solid fundamentals against near-term price pressure, with analyst consensus suggesting significant potential appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →
